Moriah Katherine Nachbaur

Moriah Katherine Nachbaur has worked in a variety of roles in the biotechnology and pharmaceutical industries since 2001. Moriah began their career as a Summer Laboratory Intern at Mendel Biotechnology, Inc. in 2001. Moriah then worked as a Laboratory Research Assistant at Dr. Raymond Erikson Lab, Harvard University in 2005 and a Writing Tutor at Harvard Extension School in the same year. In 2006, they worked as a Summer Laboratory Intern at Genentech in the Research and Development, Translational Oncology department. The following year, they worked as a Summer Intern at Genentech in the Clinical Supply Chain department. From 2008 to 2013, they worked at Coherus BioSciences in various roles, including Senior Director, Strategic Alliances & Business Development, Vice President, Product Development & Alliance Management, and Senior Vice President, Product Development. In 2019, they founded and became the Principal of MKN Biotech, Inc. and in 2022 they became the Chief Business Officer of Elixirgen Therapeutics, Inc.

Moriah Katherine Nachbaur has an A.B. in Biochemical Sciences from Harvard University, and has completed graduate coursework in Immunology and Cancer Biology from the University of California, Berkeley. Moriah also has a Graduate Certificate in Product Creation and Innovative Manufacturing from Stanford University, and has attended Crystal Springs Uplands School and The Nueva School.